Skip to main content
Clinical Trials/NCT03704155
NCT03704155
Completed
Not Applicable

Effect of Botulinum Toxin Type A Associated With Physical Therapy on the Functional Capacity of Children With Spastic Cerebral Palsy: A Randomized Controlled Clinical Trial

University of Nove de Julho0 sites24 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Botulinum toxin type A
Conditions
Cerebral Palsy, Spastic
Sponsor
University of Nove de Julho
Enrollment
24
Primary Endpoint
Severity of muscle hypertonia
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Purpose: The aim of this study was investigate the effects of botulinum toxin type A (BoNT-A) associated with physical therapy on the functional capacity of children with spastic cerebral palsy (CP). Material and methods: Twenty-four children with spastic CP were concealed and randomly assigned to the Experimental Group (EG) consisting of 12 patients treated with BoNT-A and physical therapy and Control with 12 patients treated only with physical therapy. All participants were assessed through motor and functional scales (GMFM-88, Ashworth, Berg Balance Scale, TUG test and Pediatric Evaluation of Disability Inventory) at three different times: before and after 30 days of treatment as well as 3 months after the end of treatment.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
June 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fabiano Politti

Principal Investigator

University of Nove de Julho

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of spastic Cerebral Palsy
  • Clinical diagnosis of Dynamic equine feet

Exclusion Criteria

  • Use of phenol in the last 12 months
  • Neurological blocks in the last 6 months
  • Clinical diagnosis of structured orthopedic deformities with surgical indications

Arms & Interventions

Experimental group (EG)

The EG was treated with Botulinum toxin type A and physiotherapy (stretching, balancing training, functional walking training).

Intervention: Botulinum toxin type A

Experimental group (EG)

The EG was treated with Botulinum toxin type A and physiotherapy (stretching, balancing training, functional walking training).

Intervention: Physical Therapy

Control group (CG)

GC was treated with physiotherapy (stretching, balancing training, functional walking training).

Intervention: Physical Therapy

Outcomes

Primary Outcomes

Severity of muscle hypertonia

Time Frame: 3 months

The classification of hypertonia was performed by Modified Ashworth Scale

Functional balance

Time Frame: 3 months

Functional balance was assessed using the Berg Balance Scale (BBS).

Secondary Outcomes

  • Functional mobility(3 months)
  • Functional performance(3 months)

Similar Trials

Not yet recruiting
Not Applicable
Botulinum toxin type A injections in stiff knee gait.In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gait
NL-OMON29171Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede26
Completed
Phase 4
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral PalsyCerebral Palsy Spastic Diplegia
NCT06583343Gaziosmanpasa Research and Education Hospital40
Terminated
Not Applicable
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon FracturesEquinus Contracture
NCT02051933Wake Forest University Health Sciences10
Recruiting
Phase 3
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30
Completed
Not Applicable
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34